The University of Chicago Header Logo

Connection

Yusuke Nakamura to Clinical Trials, Phase I as Topic

Back to Details
This is a "connection" page, showing publications Yusuke Nakamura has written about Clinical Trials, Phase I as Topic.
Yusuke Nakamura
Connection Strength
0.028
Clinical Trials, Phase I as Topic
  1. Identification of CDCA1-derived long peptides bearing both CD4+ and CD8+ T-cell epitopes: CDCA1-specific CD4+ T-cell immunity in cancer patients. Int J Cancer. 2014 Jan 15; 134(2):352-66.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.